Barron's Picks And Pans: FedEx, Ilumina And More

"FedEx: How It Delivers for Shareholders" by Jack Hough makes a case that even though

shares surged last week after the Memphis-based transportation and e-commerce giant offered upbeat guidance, they have another 15 to 20 percent upside in the next year as investors give it its due for steadily rising profits. In "Smurfit Kappa's Stock Merits a 40% Rise," Jonathan Buck takes a closer look at Smurfit Kappa Group. The Irish packaging company's earnings are up, and it is about to debut on the London Stock Exchange. See why the stock could add more than 40 percent in the next 12 months if the company's performance continues to improve, aided by contributions from some recent acquisitions and lower energy costs. Leslie P. Norton's "Biotech Star Illumina's Bright Future Is in Its DNA" examines why shares of

could rise as much as 50 percent as labs and cancer centers adopt its gene-sequencing gear. See why the San Diego-based biotech looks poised to rebound after a 39 percent fall as biotechs in general tumbled.

The results of the 2016 survey of Barron's readers to find the best online brokers are presented in "Best Online Brokers: Fidelity Tops Our Survey" by Theresa W. Carey. See why the number one concern of the survey respondents was security, and how Fidelity, the surprising winner, addressed those concerns. Barron's looked into the depth of the investment tools and the trading capabilities of the 16 firms to come up with this year's ranking. In Alexander Eule's cover story "30 Top CEOs Make Barron's List," find out why even though the chiefs of the FANG stocks made the cut in the annual ranking of the best chief executive officers in the world, Tim Cook of

did not. And see why a full third of the list turned over this year, due to a number of turbulent economic issues. Also in this week's Barron's:

Keep up with all the latest breaking news and trading ideas by following

on Twitter.